Company profile for Elixiron Immunotherapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Elixiron Immunotherapeutics is a biotechnology company founded in 2017 with a focus on next-generation cancer therapeutics and medicines for unmet needs in immunological and degenerative diseases. Besides EI1071, Elixiron has several other early development candidates including a potential first-in-class therapeutic antibody, EI001, for the treatment of patients with chronic hepatitis B.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
17F, No. 3 Park St. Nangang Dis., Taipei
Telephone
Telephone
+886-2-27827700
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/elixiron-closes-27m-series-a-for-alzheimer-s-and-vitiligo-clinical-trials

FIERCEBIOTECH
23 Aug 2021

https://endpts.com/kalvista-clears-international-regulatory-hurdles-on-hae-trial-elixiron-raises-27m-in-series-a/

Paul Schloesser ENDPTS
23 Aug 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty